ClinicalTrials.Veeva

Menu

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria (SCREEN ICU)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Infections, Enterobacteriaceae

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of the research is to evaluate the value of testing for ESBL carriage by rectal swab to predict the risk of ESBL-producing Enterobacteriaceae infections in intensive care.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥ 18 years old)
  • Who have been in medical or surgical intensive care at Strasbourg University Hospitals (between January 1, 2024, and January 1, 2025)
  • Who have undergone rectal screening for carriage of ESBL/HLC/carbapenemase-producing Enterobacteriaceae

Exclusion criteria

  • Refusal to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

baptiste Hoellinger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems